Jost Klawitter

Has grant

Assistant Professor

University of Denver

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jost Klawitter is an Assistant Professor at the University of Colorado Denver, United States. His research areas encompass the pharmacokinetics and metabolism of cannabinoids, as well as the role of endocannabinoids in pain and inflammation. His recent publications include studies on kidney transplantation in pediatric patients, novel treatment approaches for rheumatoid arthritis, and the effects of various cannabinoids in different clinical contexts.

Recent Grants

Grant: Close

Effects of Immunosuppressants on Cell Metabolism

Open Date: 2003-04-01

Close Date: 2007-07-01

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Collaborators (3)

Catherine Moore

Assistant Professor

Johns Hopkins University School of Medicine

UNITED STATES

View details

Susan L. Ingram

Oregon Health & Science University

UNITED STATES

View details

Joshua M. Thurman

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jost Klawitter

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Endocannabinoid Tone and Oxylipins in Rheumatoid Arthritis and Osteoarthritis—A Novel Target for the Treatment of Pain and Inflammation?

Monitoring of Allograft Adaptation After Kidney Transplantation in Pediatric Patients by Targeted Plasma Metabolomics

Human Metabolism of Sirolimus Revisited

Novel Approaches to Monitor Pharmacokinetics and Metabolism of Gemcitabine-Ibandronate Conjugate in Mice and Dogs

Pharmacokinetics of Oral Cannabinoid Δ8-Tetrahydrocannabivarin and Its Main Metabolites in Healthy Participants

Oral Cannabidiol for Seborrheic Dermatitis in Patients With Parkinson Disease: Randomized Clinical Trial

Short-Term Cannabidiol with Δ-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial

Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol in healthy adults who intermittently use cannabis

fi-Caryophyllene Inhibits Monoacylglycerol Lipase Activity and Increases 2-Arachidonoyl Glycerol Levels In Vivo: A New Mechanism of Endocannabinoid-Mediated Analgesia?

Delta(9)-Tetrahydrocannabinol Vapor Exposure Produces Conditioned Place Preference in Male and Female Rats

Collaborators (3)

Catherine Moore

Susan L. Ingram

Joshua M. Thurman

Make your next move.